Rapid Relief with Ketamine in Treating Treatment-Resistant Depression Integrating ketamine treatment into psychiatric care for treatment-resistant depression marks a significant shift in mental health treatment paradigms. Unlike traditional antidepressants, which primarily target neurotransmitters like serotonin and norepinephrine over weeks or months, ketamine acts rapidly by modulating glutamate receptors in the brain. This rapid onset can offer relief to individuals who haven't responded to conventional treatments, including myself. Having struggled with depression, I underwent ketamine infusions and experienced noticeable improvements in my mood and overall well-being within hours. However, challenges persist, such as the potential for abuse, dissociative side effects, and the need for repeated treatments to maintain effectiveness. Nevertheless, with careful monitoring and integration into comprehensive psychiatric care, ketamine presents a promising avenue for addressing treatment-resistant depression.